Zenas BioPharma
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Job Posting Salary Data
From 2 marketing roles posted in the last 12 months
Community Salary Data
Help build salary transparency at Zenas BioPharma. Share your compensation anonymously.
Reviews
Jobs
About Zenas BioPharma
Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2020
- Headquarters
- Waltham
Why Work at Zenas BioPharma?
Discover what makes Zenas BioPharma a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
